Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review

Int J Mol Sci. 2023 Aug 27;24(17):13294. doi: 10.3390/ijms241713294.

Abstract

The comprehensive narrative review conducted in this study delves into the mechanisms of communication and action at the molecular level in the human organism. The review addresses the complex mechanism involved in the microbiota-gut-brain axis as well as the implications of alterations in the microbial composition of patients with neurodegenerative diseases. The pathophysiology of neurodegenerative diseases with neuronal loss or death is analyzed, as well as the mechanisms of action of the main metabolites involved in the bidirectional communication through the microbiota-gut-brain axis. In addition, interventions targeting gut microbiota restructuring through fecal microbiota transplantation and the use of psychobiotics-pre- and pro-biotics-are evaluated as an opportunity to reduce the symptomatology associated with neurodegeneration in these pathologies. This review provides valuable information and facilitates a better understanding of the neurobiological mechanisms to be addressed in the treatment of neurodegenerative diseases.

Keywords: dysbiosis; fecal microbiota transplantation; interventions; metabolites; microbiota; neurodegenerative diseases; prebiotics; probiotics; psychobiotics.

Publication types

  • Review

MeSH terms

  • Dysbiosis / therapy
  • Fecal Microbiota Transplantation
  • Gastrointestinal Microbiome*
  • Humans
  • Metabolome
  • Neurodegenerative Diseases* / therapy

Grants and funding

This research received no external funding.